Delivery Order SPE2DX15D3020-SPE2DX24FPYCS
Award Date
8/20/24
Potential Completion Date
8/21/24
Potential Value
$12K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,805.87 firm fixed price delivery order contract has a completion date of May 2, 2024 and was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999...
This federal contract award is for the pharmaceutical product Dupixent 200 mg/1.14 ml pen, awarded to Amerisourcebergen Drug Corp's Corporate Office division. The $3,215.43 firm-fixed-price delivery order was issued by the Defense agency Medical Supply Chain, with a performance location in Conshohocken, Pennsylvania. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the Defense Logistics Agency (DLA)...
This federal contract award is for the delivery of the pharmaceutical product Dupixent 300 mg/2 ml pen, valued at $21,554.12, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is a firm-fixed price delivery order with an ultimate completion date of August 1, 2024. This award is not associated with a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor,...
The federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen 2 ml, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract has a total ceiling value of $22,336.77 and is a firm fixed-price delivery order. There was no set-aside designation for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to...
This federal contract award, valued at $38,691.31, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Dupixent 300 mg/2 ml pens to the government. Amerisourcebergen is a major pharmaceutical distribution company that holds a large Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 2025, to provide a wide range of pharmaceutical products and...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $32,672.79 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen, with a completion date of August 2, 2024. Amerisourcebergen is one of the largest pharmaceutical distributors in the United States, providing a wide range of medical commodities to federal agencies and...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, awarded by the Defense Logistics Agency (DLA) to prime contractor AmerisourceBergen Drug Corp. The $15,312.61 firm fixed price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen 2ml to the U.S. Department of Defense (DoD) and its Medical Supply Chain agency. The $29,013.39 Firm Fixed Price delivery order contract has an ultimate completion date of April 18, 2024. This award is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics...
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the delivery of Dupixent 300 mg/2 ml pens. The $2,679.25 Firm Fixed Price delivery order was issued by the U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical. This award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,890.79 firm-fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pens, with a period of performance through February 28, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a...